Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.

Gallafent JH, Buskin SE, De Turk PB, Aboulafia DM.

J Clin Oncol. 2005 Feb 20;23(6):1253-60.

PMID:
15718323
2.

Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.

Lin CY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Lo YC, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2009 Jun;42(3):227-33.

PMID:
19812856
3.

AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.

Nasti G, Talamini R, Antinori A, Martellotta F, Jacchetti G, Chiodo F, Ballardini G, Stoppini L, Di Perri G, Mena M, Tavio M, Vaccher E, D'Arminio Monforte A, Tirelli U; AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive from Antiretrovirals.

J Clin Oncol. 2003 Aug 1;21(15):2876-82.

PMID:
12885804
4.
5.

The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.

Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, Antunes F, Stellbrink HJ, Phillips AN, Lundgren JD.

Cancer. 2004 Jun 15;100(12):2644-54.

6.

Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy.

Palmieri C, Dhillon T, Thirlwell C, Newsom-Davis T, Young AM, Nelson M, Gazzard BG, Bower M.

HIV Med. 2006 Jul;7(5):291-3.

7.

Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.

Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.

Int J Oncol. 2005 Sep;27(3):779-85.

PMID:
16077928
8.
9.

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.

Bower M, Weir J, Francis N, Newsom-Davis T, Powles S, Crook T, Boffito M, Gazzard B, Nelson M.

AIDS. 2009 Aug 24;23(13):1701-6. doi: 10.1097/QAD.0b013e32832d080d.

PMID:
19550283
10.

Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.

Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.

AIDS. 2007 Jun 19;21(10):1245-52.

PMID:
17545700
11.

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Pediatric AIDS Clincial Trials Group Protocol 219C Team.

Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.

PMID:
16894075
12.
13.

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.

Nasti G, Martellotta F, Berretta M, Mena M, Fasan M, Di Perri G, Talamini R, Pagano G, Montroni M, Cinelli R, Vaccher E, D'Arminio Monforte A, Tirelli U; GICAT; ICONA.

Cancer. 2003 Dec 1;98(11):2440-6.

14.

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.

Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, Dhillon T, Holmes P, Gazzard BG, Stebbing J.

J Clin Oncol. 2005 Aug 1;23(22):5224-8.

PMID:
16051964
15.

Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.

Yoshioka MC, Alchorne MM, Porro AM, Tomimori-Yamashita J.

Int J Dermatol. 2004 Sep;43(9):643-7.

PMID:
15357742
16.

AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.

Antinori S, Ridolfo A, Fasan M, Magni C, Galimberti L, Milazzo L, Sollima S, Adorni F, Giuliani G, Galli M, Corbellino M, Parravicini C.

HIV Med. 2009 Jan;10(1):6-11. doi: 10.1111/j.1468-1293.2008.00645.x.

17.

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.

Infection. 2005 Oct;33(5-6):345-9.

PMID:
16258865
18.
20.

Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.

Asiimwe F, Moore D, Were W, Nakityo R, Campbell J, Barasa A, Mermin J, Kaharuza F.

HIV Med. 2012 Mar;13(3):166-71. doi: 10.1111/j.1468-1293.2011.00955.x. Epub 2011 Nov 24.

Supplemental Content

Support Center